Atlas Trials

Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors

Clinical trial NCT06162663 · TERMINATED

Trial details

NCT number
NCT06162663
Sponsor
Medical University of South Carolina
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Breast CancerInsomnia
Start date
2024-09-20
Primary completion
2026-01-15
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.